Know what to ask. Then build the team around you.
After a cancer diagnosis, the most powerful thing you can do is walk into each appointment knowing the right questions. This is the language behind your care — what clinical guidelines are, what the different cancer hospital labels mean, and exactly what to ask your team — translated into plain English.
“Is my plan based on the guidelines?”
What clinical guidelines are, and how your doctors use them
Cancer care isn't improvised. Behind almost every recommendation is a set of clinical guidelines — and knowing how they work tells you what to ask.
A clinical guideline is a map of the best-known path for a specific cancer. Expert panels read the strongest available research and agree on the recommended sequence of decisions — what tests to run, how to confirm the diagnosis, which treatments to consider, and how to follow up — for each cancer type, stage, and biomarker. The most widely used in the U.S. are the NCCN Guidelines, which cover roughly 97% of cancers patients face.
They're built to be trusted and to stay current. The guidelines are written by panels of more than 2,000 specialists from leading cancer centers, updated continuously as new evidence arrives, and developed without industry funding for that work. Each member institution gets a single vote, and patient advocates sit on many panels. That's why your doctor can point to a guideline as the reasoning behind a recommendation.
How a doctor actually uses them
Guidelines are the starting line, not a script. A good oncologist uses them to make sure no reasonable option is missed, to anchor a shared decision with you, and often to support insurance coverage — then tailors the plan to your body, your other health conditions, and what matters to you. If your plan differs from the guideline, that can be completely appropriate; you're entitled to understand why.
The labels on a recommendation: what "Category" means
NCCN recommendations carry a category that tells you, at a glance, how strong the evidence is and how much the experts agree. You don't need to memorize these — but recognizing them lets you ask sharper questions.
Strong evidence and unanimous expert agreement. The most settled recommendations.
Lower-level evidence but still unanimous agreement. This is where most recommendations sit.
Lower-level evidence and general — not unanimous — agreement. Reasonable, with more room for discussion.
Major disagreement among experts about whether this is appropriate. Worth a careful conversation.
Guidelines may also flag an option as preferred, other recommended, or useful in certain circumstances — describing not just what works, but what the experts would reach for first.
- Is my treatment plan consistent with the NCCN guidelines for my exact cancer type, stage, and biomarkers?
- What evidence category supports the option you're recommending for me?
- Are there other guideline-listed options for my situation — and why this one for me?
- If my plan differs from the guideline, what's the reasoning?
“Where should I be treated?”
NCI-designated, NCCN, PPS-exempt — what each label actually tells you
These three terms get used as if they mean the same thing. They don't. Each answers a different question — and together they help you judge where to go for complex care.
A federal designation awarded to centers that meet rigorous standards for cancer research, renewed through intense review every five years. The top tier — “Comprehensive” — must excel across laboratory, clinical, and population research.
An alliance of leading cancer centers whose specialists write the NCCN Guidelines — the most thorough and frequently updated cancer guidelines in medicine, recognized by Medicare and private insurers.
A small group of cancer hospitals that Congress exempted from Medicare's standard fixed-price payment system, because their research-intensive, specialized care didn't fit the standard model. It's a payment category, not a clinical score.
Questions that build the right care team
You don't need to be an expert — you need the right questions. Print this, or keep it on your phone, and check off what you've covered.
Understanding my diagnosis
My team and where I'm treated
My options and the guidelines behind them
Trials, second opinions, and next steps
◆ Tip: a second opinion is your right, and a good team will welcome it — especially for a rare, aggressive, or complex cancer.
Ready to put this into motion?
Find where you are in your journey, and we'll point you to the right next step — and the right team.